Rentschler Biopharma is a global leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers customized full-service solutions for bioprocess development and manufacturing of complex biopharmaceuticals, along with related consulting activities, project management, and regulatory support. With over 50 years of experience, Rentschler Biopharma contributes significantly to the worldwide availability of essential medicines, including biopharmaceuticals for serious or rare diseases.